BRAF mutation and AKAP9 expression in sporadic papillary thyroid carcinomas

Pathology - Tập 38 - Trang 201-204 - 2006
Ju-Han Lee1, Eung Seok Lee1, Young-Sik Kim1, Nam Hee Won1, Yang-Seok Chae1
1Department of Pathology, College of Medicine, Korea University, Seoul, Korea

Tài liệu tham khảo

Davies, 2002, Mutations of the BRAF gene in human cancer, Nature, 417, 949, 10.1038/nature00766 Kimura, 2003, High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS- BRAF signaling pathway in papillary thyroid carcinoma, Cancer Res, 63, 1454 Cohen, 2003, BRAF mutation in papillary thyroid carcinoma, J Natl Cancer Inst, 95, 625, 10.1093/jnci/95.8.625 Soares, 2003, BRAF mutations and RET/ PTC rearrangements are alternative events in the etiopathogenesis of PTC, Oncogene, 22, 4578, 10.1038/sj.onc.1206706 Xu, 2003, High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines, Cancer Res, 63, 4561 Namba, 2003, Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers, J Clin Endocrinol Metab, 88, 4393, 10.1210/jc.2003-030305 Fukushima, 2003, BRAF mutations in papillary carcinomas of the thyroid, Oncogene, 22, 6455, 10.1038/sj.onc.1206739 Nikiforova, 2003, BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas, Clin Endocrinol Metab, 88, 5399, 10.1210/jc.2003-030838 Xing, 2004, BRAF T1796A transversion mutation in various thyroid neoplasms, J Clin Endocrinol Metab, 89, 1365, 10.1210/jc.2003-031488 Kim, 2004, Mutations of the BRAF gene in papillary thyroid carcinoma in a Korean population, Yonsei Med J, 45, 818, 10.3349/ymj.2004.45.5.818 Puxeddu, 2004, BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas, J Clin Endocrinol Metab, 89, 2414, 10.1210/jc.2003-031425 Fugazzola, 2004, BRAF mutations in an Italian cohort of thyroid cancers, Clin Endocrinol (Oxf), 61, 239, 10.1111/j.1365-2265.2004.02089.x Ciampi, 2005, Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer, J Clin Invest, 115, 94, 10.1172/JCI23237 Peyssonnaux, 2001, The Raf/MEK/ERK pathway: new concepts of activation, Biol Cell, 93, 53, 10.1016/S0248-4900(01)01125-X Avruch, 2001, Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade, Recent Prog Horm Res, 56, 127, 10.1210/rp.56.1.127 Kolch, 2000, Meaningful relationships: the regulation of the Ras/Raf/ MEK/ERK pathway by protein interactions, Biochem J, 351, 289, 10.1042/bj3510289 Mercer, 2003, Raf proteins and cancer: B-Raf is identified as a mutational target, Biochim Biophys Acta, 1653, 25 Sithanandam, 1992, B-raf and a B-raf pseudogene are located on 7q in man, Oncogene, 7, 795 Edwards, 2000, A-kinase anchoring proteins: protein kinase A and beyond, Curr Opin Cell Biol, 12, 217, 10.1016/S0955-0674(99)00085-X Witczak, 1999, Cloning and characterization of a cDNA encoding an A-kinase anchoring protein located in the centrosome, AKAP450, EMBO J, 18, 1858, 10.1093/emboj/18.7.1858 Takahashi, 1999, Characterization of a novel giant scaffolding protein, CG- NAP, that anchors multiple signaling enzymes to centrosome and the golgi apparatus, J Biol Chem, 274, 17267, 10.1074/jbc.274.24.17267 Schmidt, 1999, AKAP350, a multiply spliced protein kinase A-anchoring protein associated with centro- somes, J Biol Chem, 274, 3055, 10.1074/jbc.274.5.3055